Roche Holding AG

175 articles about Roche Holding AG

• Roche Holding AG Drug Tandem Extends Life of Some Lung-Cancer Patients

  5/20/2011

• Roche Holding AG's Avastin Treatment Effective for Blindness in Study

  4/29/2011

• Roche Holding AG's T-DM1 Treatment Halted Spread of Breast Cancer in Mid-Stage Study

  4/8/2011

• Roche Holding AG Founder's Family Loses Voting Majority as Shareholder Leaves Group

  3/25/2011

• Roche Holding AG To Buy Diagnostics Company PVT For $91 Million Upfront Plus Up To $28 Million in Milestones

  3/16/2011

• Roche Holding AG Said to Return Diabetes Drug Rights to Ipsen Because of Side Effects

  2/1/2011

• Plexxikon Inc., Roche Holding AG Report Overall Survival Benefit for Melanoma Patients in PLX4032 Phase 3 Trial

  1/19/2011

• Biogen Idec, Inc. (Massachusetts), Roche Holding AG's Genentech End Dispute Over Rituxan Follow-Ons

  10/22/2010

• FDA Approves Roche Holding AG Drug Herceptin For Advanced Stomach Cancer

  10/21/2010

• Cocktails Are Next For Cancer-Drug Makers; Big Pharma Like Roche Holding AG,AstraZeneca PLC, and Sanofi-Aventis (France) Turns to the Multi-drug Approach that Transformed AIDS

  8/27/2010

• Roche Holding AG Wins Reversal of $10.5 Million Accutane Verdict in New Jersey Case

  8/6/2010

• UK's NICE Recommends Roche Holding AG's MabThera For Leukemia

  7/28/2010

• Roche Holding AG Profit Rises 58% on Lower Integration Costs

  7/23/2010

• Roche Holding AG, Johnson & Johnson and Biogen Idec, Inc. (Massachusetts) Prodded by FDA for More Neglected Disease Medicines

  6/18/2010

• Roche Holding AG Stops Enrolment into Avastin Trial

  6/3/2010

• Teva Pharmaceutical Industries Limited Targets Roche Holding AG's Rituxan in Biosimilar Drug Trial

  5/25/2010

• Roche Holding AG And Biogen Idec, Inc. (California)'s Rituxan Halves Risk Of Lymphoma Recurrence According to Phase III Study

  5/21/2010

• US Warns Roche Holding AG, Shire plc on Misleading Drug Promotions

  5/6/2010

• US FDA Says Sanofi-Aventis (France), Roche Holding AG Promotions Misleading

  4/26/2010

• Roche Holding AG to Ask FDA to Approve Targeted Breast Cancer Drug Early

  4/15/2010